| Prepared By |
| |
Jane Cole Finlay
, MD, FRCPC
|
| Reviewed By |
| |
Marina Salvadori
|
| |
Vivien Brown
, MDCM, CCFP, FCFP
|
| |
Lydia Hatcher
, MD, CCMF, FCFP
|
| |
Bruce H. Wheeler
, MD, CCFP
|
| |
Carl Fournier
, MD, CCFP
|
| |
Phyllis Bedder
, MD
|
| |
| Reviewed By |
| |
Wendy Vaudry
, MD, FRCPC
|
| |
Parvaz Madadi
, PhD
|
| |
Marie Lambert
, MD, FRCPC
|
| |
Robert Gow
, MD, BS, FRACP, FRCPC
|
| |
Robert Harrison
, MD, PhD, Dsc
|
| |
Ran Goldman
, MD, FRCPC, MSc
|
| |
| Reviewed By |
| |
Martin Gignac
, MD, FRCPC
|
| |
Diane Sacks
, MD, FRCP(C)
|
| |
| Reviewed By |
| |
Bruno Maranda
, MD, MSc, FRCPC, FCCMG
|
| |
Sylvia Stockler
, MD, MBA (Austria)
|
| |
| Reviewed By |
| |
François Boucher
, MD, FRCPC
|
| |
James Kellner
, MD
|
| |
Nandini Sathi
, MD, CCFP
|
| |
Phyllis Bedder
, MD
|
| |
Lydia Hatcher
, MD, CCMF, FCFP
|
| |
Carol McConnery
, MD
|
| |
Bruce H. Wheeler
, MD, CCFP
|
| |
| Reviewed By |
| |
Nicole Le Saux
, MD FRCP (C)
|
| |
Mark Awuku
, MB ChB FRCP(C) FAAP
|
| |
Nandini Sathi
, MD CCFP
|
| |
David Reid
, MD
|
| |
Carol McConnery
, MD
|
| |
Phyllis Bedder
, MD
|
| |
Beth Watts
, MD
|
| |
|
Invasive Meningococcal DiseaseLearning Objectives- Examine the epidemiology of invasive meningococcal disease (IMD) in Canada, including changing epidemiological trends
- Review the etiology, transmission, clinical features and complications of meningococcal sepsis and meningitis
- Discuss the evidence-based management of meningococcal meningitis
- Identify approaches to the prevention of IMD, including vaccination of various age groups, prevention in travellers, and compare the different meningococcal vaccines currently available.
- Discuss upcoming advances in the prevention of IMD caused by N. meningitidis type B
- Review the Canadian National Advisory Committee on Immunization (NACI) update (2009) on meningococcal disease and vaccination
Paediatric Update - 2009Learning Objectives - Understand the current issues/controversies in paediatric medicine.
- Identify at risk populations to prevent disease or accidental exposure.
- Apply this learning to better manage and counsel your patients to treat and prevent disease/environmental exposure.
ADHD: Measuring Outcomes Beyond the Classroom(En Francais)Learning Objectives - the underlying causes that have contributed to the rapid rise in the diagnosis and treatment of ADHD over the past 2 decades;
- the strategies to ad parents and families in the management of ADHD;
- a broader definition of success as it relates to the positive treatment outcomes, including outcomes beyond the classroom;
- various concepts, such as the one of Wellness, into practical measures when assessing outcomes of a successful ADHD management;
- the current stimulant medications and readiness for the upcoming new generation.
Pneumococcal Virtual Practice UpdatedLearning Objectives:- Understand risks of acute and long term complications of pneumococcal infections
- Be able to explain the benefits and possible adverse events of pneumococcal vaccines.
- Understand what underlying conditions increase the risk of pneumococcal infections.
- Understand patient concerns about vaccination and their limited preoccupation regarding the disease.
- Apply the concepts learned to better counsel patients on available options for preventing pneumococcal infection.
Prevention of Gastroenteritis in Early Childhood(En Francais)Learning Objectives- To understand the epidemiology and pathogenesis of rotavirus infection among children under 5 years of age.
- To understand strategies for limiting transmission and reducing the severity of rotavirus gastroenteritis.
- To describe the impact of rotavirus gastroenteritis (RGE) on patients, the community and health care resources.
- To become familiar with proper treatment and management of rotavirus gastroenteritis.
- To understand the principles underlying rotavirus vaccinations, the characteristics of the new rotavirus vaccines, and how rotavirus vaccination can be incorporated into regular practice.
|
